The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
Product characteristics associated with in vivo expansion of anti-CD19 CAR T cells in patients treated with axicabtagene ciloleucel (axi-cel).
 
Frederick Lundry Locke
Consulting or Advisory Role - Cellular Biomedicine Group; Kite, a Gilead company
Research Funding - Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Moffitt (Inst)
 
John Rossi
No Relationships to Disclose
 
Sattva Swarup Neelapu
Consulting or Advisory Role - Biovest; Celgene; Medivation; Merck Sharp & Dohme; XEME BioPharma
Speakers' Bureau - Dava Oncology; Dava Oncology
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; CureTech; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics
Travel, Accommodations, Expenses - Dava Oncology; Dava Oncology
 
Allen Xue
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Amgen; Kite, a Gilead company
 
Marc Better
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Xiao Zhang
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Armin Ghobadi
No Relationships to Disclose
 
Lazaros J. Lekakis
No Relationships to Disclose
 
David Bernard Miklos
Consulting or Advisory Role - Adaptive Biotechnologies; Genentech; Kite, a Gilead company; Pharmacyclics; Sanofi; Velos
Research Funding - Pharmacyclics
Patents, Royalties, Other Intellectual Property - Pharmacyclics
Travel, Accommodations, Expenses - Pharmacyclics; Sanofi
 
Caron Alyce Jacobson
Consulting or Advisory Role - Kite, a Gilead company; Pharmacyclics
 
Ira Braunschweig
Stock and Other Ownership Interests - Kite, a Gilead company
 
Olalekan O. Oluwole
No Relationships to Disclose
 
Tanya Siddiqi
Speakers' Bureau - Pharmacyclics; Seagen
 
Yi Lin
Research Funding - Janssen
 
John Timmerman
No Relationships to Disclose
 
Patrick Michael Reagan
Research Funding - Seagen
 
Lynn Navale
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
William Y. Go
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Jeffrey S. Wiezorek
Employment - Kite, a Gilead company
Leadership - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Adrian Bot
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company